Manouchehr Moghaddam

Title: Manouchehr Moghaddam: Innovator in Medical Diagnostics

Introduction

Manouchehr Moghaddam is a notable inventor based in Waukesha, WI (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of heparin-induced thrombocytopenia (HITP). His innovative approach has the potential to improve patient outcomes in clinical settings.

Latest Patents

Moghaddam holds a patent for a method of detecting heparin-induced antibodies, which is crucial for diagnosing HITP. This method involves binding human platelet factor 4 to a linear, non-glycosaminoglycan polymer that carries negative charges distributed along the polymer chain. The negative charge is less than 10 angstroms from the polymer chain, and in some embodiments, it is a strong negative charge. The process forms a complex with one or more epitopes that are recognizable by antibodies generated in a HITP immune response. Blood plasma or serum from a patient suspected of having HITP is then contacted with this complex to analyze the presence of HITP-related antibodies. Additionally, a kit for diagnosing HITP is also disclosed in his patent.

Career Highlights

Throughout his career, Moghaddam has worked with reputable organizations such as the BloodCenter Research Foundation and the Genetics Testing Institute. His work in these institutions has allowed him to advance his research and contribute to the medical field significantly.

Collaborations

Some of his notable coworkers include Gian Visentin and Richard H. Aster. Their collaboration has likely enriched the research environment and fostered innovative solutions in medical diagnostics.

Conclusion

Manouchehr Moghaddam's contributions to the field of medical diagnostics, particularly through his patent on detecting heparin-induced thrombocytopenia, highlight his role as an innovator. His work continues to impact the medical community positively.